Clinical trial
Tamoxifen Pharmacogenetics and Clinical Effects
NCT00228930 · National Institute of General Medical Sciences (NIGMS), NIH · Completed
Key facts
| NCT number | NCT00228930 |
|---|---|
| Title | Tamoxifen Pharmacogenetics and Clinical Effects |
| Official title | A Pilot Trial Correlating Metabolic Profile of Tamoxifen With Pharmacogenetic Predictors and Clinical Effects |
| Lead sponsor | National Institute of General Medical Sciences (NIGMS), NIH |
| Collaborators | Indiana University School of Medicine |
| Status | Completed |
| Study type | Observational |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | Tamoxifen (pharmacodynamic analysis) |
| Enrollment | 297 |
| Start date | Sep 1, 2002 |
| Completion | Aug 1, 2007 |
| First posted | Sep 29, 2005 |
| Last update posted | Sep 25, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: